# Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.

> **NCT00555061** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 60 (actual)

## Conditions studied

- Skin Infections, Bacterial

## Interventions

- **DRUG:** Retapamulin Ointment, 1%

## Key facts

- **NCT ID:** NCT00555061
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555061, "Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00555061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*